Publikationstyp: Beitrag in wissenschaftlicher Zeitschrift
Art der Begutachtung: Peer review (Publikation)
Titel: A collaborative journey towards the late‐stage functionalization of added‐value chemicals using engineered halogenases
Autor/-in: Büchler, Johannes
Hegarty, Eimear
Schroer, Kirsten
Snajdrova, Radka
Turner, Nicholas J.
Loiseleur, Olivier
Buller, Rebecca
Le Chapelain, Camille
et. al: No
DOI: 10.1002/hlca.202200128
Erschienen in: Helvetica Chimica Acta
Band(Heft): 106
Heft: 1
Seite(n): e202200128
Erscheinungsdatum: 2022
Verlag / Hrsg. Institution: Wiley
ISSN: 0018-019X
1522-2675
Sprache: Englisch
Schlagwörter: Biocatalysis; Enzyme engineering; Collaboration; Halogenation; Late-stage functionalization; Sustainable chemistry
Fachgebiet (DDC): 660: Technische Chemie
Zusammenfassung: In 2017, two companies, Novartis AG and Syngenta AG, joined forces with the group of Prof. Buller, head of the Competence Center for Biocatalysis (CCBIO), to tackle the challenge of enzymatic late-stage halogenation. This biocatalytic method was considered to provide a more sustainable approach to late-stage halogenation of complex molecules than traditional synthetic approaches. Using machine-learning guided protein engineering, α-ketoglutarate dependent halogenases were evolved into versatile catalysts capable of selectively chlorinating inactivated C−H bonds. Structurally diverse molecules, namely an analogue of martinelline as well as two members of the soraphen natural product family, were enzymatically chlorinated at two distinct positions in a regio- and stereoselective manner, thus demonstrating the synthetic usefulness of such a strategy. As part of our three-year collaboration, flavin-dependent halogenases were also studied.
URI: https://digitalcollection.zhaw.ch/handle/11475/26410
Volltext Version: Publizierte Version
Lizenz (gemäss Verlagsvertrag): Lizenz gemäss Verlagsvertrag
Departement: Life Sciences und Facility Management
Organisationseinheit: Institut für Chemie und Biotechnologie (ICBT)
Enthalten in den Sammlungen:Publikationen Life Sciences und Facility Management

Dateien zu dieser Ressource:
Es gibt keine Dateien zu dieser Ressource.
Zur Langanzeige
Büchler, J., Hegarty, E., Schroer, K., Snajdrova, R., Turner, N. J., Loiseleur, O., Buller, R., & Le Chapelain, C. (2022). A collaborative journey towards the late‐stage functionalization of added‐value chemicals using engineered halogenases. Helvetica Chimica Acta, 106(1), e202200128. https://doi.org/10.1002/hlca.202200128
Büchler, J. et al. (2022) ‘A collaborative journey towards the late‐stage functionalization of added‐value chemicals using engineered halogenases’, Helvetica Chimica Acta, 106(1), p. e202200128. Available at: https://doi.org/10.1002/hlca.202200128.
J. Büchler et al., “A collaborative journey towards the late‐stage functionalization of added‐value chemicals using engineered halogenases,” Helvetica Chimica Acta, vol. 106, no. 1, p. e202200128, 2022, doi: 10.1002/hlca.202200128.
BÜCHLER, Johannes, Eimear HEGARTY, Kirsten SCHROER, Radka SNAJDROVA, Nicholas J. TURNER, Olivier LOISELEUR, Rebecca BULLER und Camille LE CHAPELAIN, 2022. A collaborative journey towards the late‐stage functionalization of added‐value chemicals using engineered halogenases. Helvetica Chimica Acta. 2022. Bd. 106, Nr. 1, S. e202200128. DOI 10.1002/hlca.202200128
Büchler, Johannes, Eimear Hegarty, Kirsten Schroer, Radka Snajdrova, Nicholas J. Turner, Olivier Loiseleur, Rebecca Buller, and Camille Le Chapelain. 2022. “A Collaborative Journey towards the Late‐Stage Functionalization of Added‐Value Chemicals Using Engineered Halogenases.” Helvetica Chimica Acta 106 (1): e202200128. https://doi.org/10.1002/hlca.202200128.
Büchler, Johannes, et al. “A Collaborative Journey towards the Late‐Stage Functionalization of Added‐Value Chemicals Using Engineered Halogenases.” Helvetica Chimica Acta, vol. 106, no. 1, 2022, p. e202200128, https://doi.org/10.1002/hlca.202200128.


Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt, soweit nicht anderweitig angezeigt.